COSMO Pharmaceuticals SA (0RGI) - Total Liabilities

Latest as of June 2025: £143.35 Million GBP ≈ $192.51 Million USD

Based on the latest financial reports, COSMO Pharmaceuticals SA (0RGI) has total liabilities worth £143.35 Million GBP (≈ $192.51 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore COSMO Pharmaceuticals SA annual equity growth to track the company's year-over-year net asset growth rate.

COSMO Pharmaceuticals SA - Total Liabilities Trend (2004–2024)

This chart illustrates how COSMO Pharmaceuticals SA's total liabilities have evolved over time, based on quarterly financial data. See 0RGI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

COSMO Pharmaceuticals SA Competitors by Total Liabilities

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their total liabilities.

Company	Country	Total Liabilities
Palfinger AG VI:PAL	Austria	€1.35 Billion
Yapp Automotive Systems Co Ltd SHG:603013	China	CN¥2.44 Billion
WEIBO CORP. A F:2WB	Germany	€3.08 Billion
North China Pharmaceutical Co Ltd SHG:600812	China	CN¥14.52 Billion
Csg Smart Science&Technology Co Ltd SHE:300222	China	CN¥2.83 Billion
Three's Company Media Group Co Ltd SHG:605168	China	CN¥1.64 Billion
Flow Traders BV AS:FLOW	Netherlands	€15.08 Billion
Faraday Copper Corp. TO:FDY	Canada	CA$15.27 Million

Liability Composition Analysis (2004–2024)

This chart breaks down COSMO Pharmaceuticals SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see COSMO Pharmaceuticals SA (0RGI) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.84	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how COSMO Pharmaceuticals SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for COSMO Pharmaceuticals SA (2004–2024)

The table below shows the annual total liabilities of COSMO Pharmaceuticals SA from 2004 to 2024.

Year	Total Liabilities	Change
2024-12-31	£141.68 Million ≈ $190.26 Million	+13.40%
2023-12-31	£124.94 Million ≈ $167.79 Million	-57.76%
2022-12-31	£295.80 Million ≈ $397.24 Million	+1.00%
2021-12-31	£292.88 Million ≈ $393.32 Million	+49.40%
2020-12-31	£196.04 Million ≈ $263.26 Million	+2.41%
2019-12-31	£191.43 Million ≈ $257.07 Million	+5.86%
2018-12-31	£180.83 Million ≈ $242.84 Million	+549.14%
2017-12-31	£27.86 Million ≈ $37.41 Million	-0.21%
2016-12-31	£27.92 Million ≈ $37.49 Million	-18.60%
2015-12-31	£34.30 Million ≈ $46.06 Million	-53.23%
2014-12-31	£73.33 Million ≈ $98.48 Million	+220.94%
2013-12-31	£22.85 Million ≈ $30.68 Million	-16.13%
2012-12-31	£27.24 Million ≈ $36.59 Million	+86.55%
2011-12-31	£14.60 Million ≈ $19.61 Million	-56.35%
2010-12-31	£33.46 Million ≈ $44.93 Million	+186.73%
2009-12-31	£11.67 Million ≈ $15.67 Million	-19.68%
2008-12-31	£14.53 Million ≈ $19.51 Million	+20.26%
2007-12-31	£12.08 Million ≈ $16.22 Million	-33.86%
2006-12-31	£18.27 Million ≈ $24.53 Million	-33.77%
2005-12-31	£27.58 Million ≈ $37.04 Million	+13.30%
2004-12-31	£24.34 Million ≈ $32.69 Million	--

About COSMO Pharmaceuticals SA

LSE:0RGI UK

Market Cap

$1.25 Billion

£927.14 Million GBP

Market Cap Rank

#7977 Global

#24 in UK

Share Price

£61.80

Change (1 day)

+0.98%

52-Week Range

£55.20 - £125.25

All Time High

£173.85